Miller Fisher−Guillain−Barré overlap syndrome during the Zika Virus outbreak
Abstract
Keywords
Full Text:
PDFReferences
Dirlikov E, Ryff KR, Torres–Aponte J, et al. Update: Ongoing Zika virus transmission–Puerto Rico. MMWR Morb Mortal Wkly Rep 2016; 65(17):451–55.
Sharp TM, Muñoz–Jordán J, Perez–Padilla J, et al. Zika virus associated with severe thrombocytopenia. Clin Infect Dis 2016; 63(9):1198–1201.
Cao–Lormeau V, Blake A, Mons S, et al. Guillain–Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case–control study. Lancet 2016; 387(10027):1531-1539.
Hennessey M, Fischer M, Staples E. Zika virus spreads to new areas – region of the Americas, May 2015–January 2016. MMWR Morb Mortal Wkly Rep 2016; 65(3):55–58.
Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012; 366(24):2294-2304.
Yepishin IV, Allison RZ, Kaminskas DA, Zagorski NM, Liow KK. Miller Fisher syndrome: A case report highlighting heterogeneity of clinical features and focused differential diagnosis. Hawaii J Med Public Health 2016; 75(7):196-199.
Dirlikov E, Major CE, Mayshack M, et al. Guillain-Barré syndrome during ongoing Zika Virus transmission – Puerto Rico, January 1–July 31, 2016. MMWR Morb Mortal Wkly Rep 2016; 65(34):910-914.
Dirlikov E, Kniss K, Major C, et al. Guillain–Barré syndrome and healthcare needs during Zika virus transmission, Puerto Rico, 2016. Emerg Infect Dis 2017; 23(1):134-136.
Salinas JL, Major CG, Pastula DM, et al. Incidence and clinical characteristics of Guillain–Barré syndrome before the introduction of Zika virus in Puerto Rico. J Neurol Sci 2017. doi: 10.1016/j.jns.2017.04.006
dos Santos T, Rodriguez A, Almiron M, et al. Zika virus and Guillain-Barré syndrome–Case series from seven countries. N Engl J Med 2016; 375:1598-1601.
Pan American Health Organization. Guidelines for surveillance of Zika virus disease and its complications. Washington, D.C.: PAHO, 2016. [http://iris.paho.org/xmlui/bitstream/handle/123456789/28405/9789275118948_eng.pdf?sequ-ence=1&isAllowed=y available at 26.12.2017]
Adams L, Bello–Pagán M, Lozier M, et al. Update: Ongoing Zika virus transmission – Puerto Rico. MMWR Morb Mortal Wkly Rep 2016; 65(30):774–779.
Rabe IB, Staples JE, Villanueva J, et al. Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep 2016; 65.
Guidance for U.S. Laboratory testing for Zika virus infection: Implications for health care providers. MMWR Morb Mortal Wkly Rep 2016; 65(46):1304.
Sever M, Aksay E, Gulec F. The diagnosis is made only with suspicion: Miller Fisher syndrome. Hong Kong Jour Emerg Med 2011; 18(6):428-431.
Wakerley BR, Yuki N. Mimics and chamaleons in Guillain–Barré and Miller Fisher syndromes. Pract Neurol 2015; 15(2):90-99.
Sejvar JJ, Hohl KS, Gidudu J, et al. Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011; 29:599–612.
Farmakidis C, Inan S, Milstein M, Herskovitz S. Headache and pain in Guillain–Barré syndrome. Curr Pain Headache Rep 2015; 19:40.
Pirotta T, Chircop C, Vella N. Is headache a common symptom in Miller Fisher syndrome? – two case reports. J Autoimmun Res 2016; 3(1):1011.
Friedman DI, Potts E. Headache associated with Miller Fisher syndrome. Headache 2007; 1347–1348.
Cherin P, Marie I, Michallet M, et al. Management of adverse events in the treatment of patients with immunoglubin therapy: A review of evidence. Autoimmun Rev 2015; 15(2016):71–81.
Odaka M, Yuki N, Hirata K. Anti–GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001; 70:50–55.
DOI: http://dx.doi.org/10.22551/2017.17.0404.10115
Copyright (c) 2017 Wilma González–Barreto, Gloria M. Rodríguez–Vega, Patricia De Jesús–Umpierre, José R. Rodríguez–Vázquez
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975